<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001493152-25-012122</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Yap Kim Choy -->
          <cik>0002081554</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/01/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001130166</issuerCik>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerCusip>23254L876</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>Level 10, Tower 11, Avenue 5,</com:street1>
          <com:street2>No. 8 Jalan Kerinchi,</com:street2>
          <com:city>Kuala Lumpur</com:city>
          <com:stateOrCountry>N8</com:stateOrCountry>
          <com:zipCode>07922</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Yap Kim Choy</reportingPersonName>
      <citizenshipOrOrganization>N8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>872000.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>872000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>872000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>20.76</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>The reporting person's ownership consists of (i) 218,000 shares of common stock, (ii) 218,000 series A warrants to purchase shares of common stock, (iii) 218,000 series B warrants to purchase shares of common stock, and (iv) 218,000 series C warrants to purchase shares of common stock (the series A warrants, series B warrants and series C warrants, collectively, the "Warrants")</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>Level 10, Tower 11, Avenue 5, No. 8 Jalan Kerinchi, Kuala Lumpur, Malaysia</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Yap Kim Choy</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>18-25-3A THE WHARF RESIDENCE TAMAN PUCHONG PRIMA PUCHONG 47200 SELANGOR MALAYSIA</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Malaysia</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>872,000</amountBeneficiallyOwned>
        <classPercent>20.76%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>872,000</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>872,000</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>Form of Amended and Restated Series A Common Stock Warrant

Form of Amended and Restated Series B Common Stock Warrant

Form of Amended and Restated Series C Common Stock Warrant

sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-1.htm

sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-2.htm

sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-3.htm

sec.gov/Archives/edgar/data/1130166/000164117225015874/ex10-4.htm</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Yap Kim Choy</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Yap Kim Choy</signature>
        <title>Yap Kim Choy</title>
        <date>09/01/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
